Inventor

Charles G. Clark

Inventor
Cherry Hill, NJ, US

Overview

24→
Patents
1985–2021
Patent span
Chemistry
Primary field (CPC C)

Patents· 24 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

C07Dprimary
C07DHeterocyclic compounds40%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations28%
C07CAcyclic or carbocyclic compounds4%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium4%
A63BApparatus for physical training, gymnastics, swimming, climbing, or fencing2%
B60JWindows, windscreens, non-fixed roofs, doors, or similar devices for vehicles2%
B60NSeats specially adapted for vehicles2%
B60QArrangement of signalling or lighting devices, the mounting or supporting thereof or circuits therefor, for vehicles in general2%
B60RVehicles, vehicle fittings, or vehicle parts, not otherwise provided for2%
D05BSewing2%
PatentTitleYear
10,926,717Vehicle with integrated portable wireless speaker system20219,428,504'7-hydroxy-spiropipiperidine indolinyl antagonists of P2Y1 receptor'20169,403,774'Guanidine and amine substituted tetrahydroisoquinoline compounds as factor xia inhibitors'20169,315,519'Guanidine substituted tetrahydroisoquinoline compounds as factor XIa inhibitors'20169,108,981'Cyclic P1 linkers as factor XIa inhibitors'20158,901,115'Cyclic P1 linkers as factor XIa inhibitors'20147,960,569'Indole antagonists of P2Y1 receptor useful in the treatment of thrombotic conditions'20117,674,828'Urea antagonists of P2Y1receptor useful in the treatment of thrombotic conditions'20107,388,021'Urea antagonists of P2Y1 receptor useful in the treatment of thrombotic conditions'20087,381,732'Pyrazolobenzamides and derivatives as factor Xa inhibitors'20087,235,575'Guanidine mimics as factor Xa inhibitors'20076,958,356'Guanidine mimics factor Xa inhibitors'20056,906,070'Guanidine mimics as factor Xa inhibitors'20056,858,616'Nitrogen containing heterobicycles as factor Xa inhibitors'20056,839,992'Quilting frame apparatus'20056,673,810'Imidazo-heterobicycles as factor Xa inhibitors'20046,602,871'Thrombin or factor Xa inhibitors'20036,541,639'Efficient ligand-mediated Ullmann coupling of anilines and azoles'20036,500,855'Thrombin or factor Xa inhibitors'20026,413,980'Nitrogen containing heterobicycles as factor Xa inhibitors'20026,403,583'Thrombin or factor Xa inhibitors'20026,369,227'Thrombin or factor Xa inhibitors'20026,339,099'Guanidine mimics as factor Xa inhibitors'20024,540,171'Variable resistance exercise apparatus'1985

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

1985–2014Patents assigned to CLARK CHARLES G (2)· patent assignee history
1985Based in Westland, MI, US· patent location history
2002–2005Patents assigned to BRISTOL MYERS SQUIBB PHARMA CO (9)· patent assignee history
2002–2016Based in Cherry Hill, NJ, US· patent location history
2005Based in Breckenridge, TX, US· patent location history
2007–2016Patents assigned to BRISTOL MYERS SQUIBB CO (10)· patent assignee history
2021Patents assigned to BERG MATTHEW A (1)· patent assignee history
2021Patents assigned to CLARK COBY S (1)· patent assignee history
2021Based in Troy, MI, US· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
BRISTOL MYERS SQUIBB CO102007–2016
BRISTOL MYERS SQUIBB PHARMA CO92002–2005
CLARK CHARLES Gself21985–2014
BERG MATTHEW A12021
CLARK COBY Sself12021
Locations
LocationPatentsSpan
Cherry Hill, New Jersey, US212002–2016
Troy, MI, US12021
Breckenridge, Texas, US12005
Westland, MI, US11985